654 related articles for article (PubMed ID: 27210504)
1. Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis.
Sinha S; Khan S; Shukla S; Lakra AD; Kumar S; Das G; Maurya R; Meeran SM
Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):41-56. PubMed ID: 27210504
[TBL] [Abstract][Full Text] [Related]
2. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis.
Shukla S; Sinha S; Khan S; Kumar S; Singh K; Mitra K; Maurya R; Meeran SM
Sci Rep; 2016 Feb; 6():21860. PubMed ID: 26905250
[TBL] [Abstract][Full Text] [Related]
3. Cucurbitacin B suppresses metastasis mediated by reactive oxygen species (ROS) via focal adhesion kinase (FAK) in breast cancer MDA-MB-231 cells.
Luo WW; Zhao WW; Lu JJ; Wang YT; Chen XP
Chin J Nat Med; 2018 Jan; 16(1):10-19. PubMed ID: 29425586
[TBL] [Abstract][Full Text] [Related]
4. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
5. Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion.
Zhang T; Li J; Dong Y; Zhai D; Lai L; Dai F; Deng H; Chen Y; Liu M; Yi Z
Breast Cancer Res Treat; 2012 Sep; 135(2):445-58. PubMed ID: 22842972
[TBL] [Abstract][Full Text] [Related]
6. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
[TBL] [Abstract][Full Text] [Related]
7. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
8. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.
Wang S; Liu Q; Zhang Y; Liu K; Yu P; Liu K; Luan J; Duan H; Lu Z; Wang F; Wu E; Yagasaki K; Zhang G
Mol Cancer; 2009 Oct; 8():81. PubMed ID: 19796390
[TBL] [Abstract][Full Text] [Related]
9. JSI-124 (Cucurbitacin I) inhibits tumor angiogenesis of human breast cancer through reduction of STAT3 phosphorylation.
Qi J; Xia G; Huang CR; Wang JX; Zhang J
Am J Chin Med; 2015; 43(2):337-47. PubMed ID: 25787299
[TBL] [Abstract][Full Text] [Related]
10. Gambogic acid exhibits anti-metastatic activity on malignant melanoma mainly through inhibition of PI3K/Akt and ERK signaling pathways.
Li CY; Wang Q; Wang XM; Li GX; Shen S; Wei XL
Eur J Pharmacol; 2019 Dec; 864():172719. PubMed ID: 31586634
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
12. Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-κB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells.
Park JH; Cho YY; Yoon SW; Park B
Int J Oncol; 2016 Sep; 49(3):1230-40. PubMed ID: 27573547
[TBL] [Abstract][Full Text] [Related]
13. Cucurbitacin B inhibits tumor angiogenesis by triggering the mitochondrial signaling pathway in endothelial cells.
Piao XM; Gao F; Zhu JX; Wang LJ; Zhao X; Li X; Sheng MM; Zhang Y
Int J Mol Med; 2018 Aug; 42(2):1018-1025. PubMed ID: 29717773
[TBL] [Abstract][Full Text] [Related]
14. Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling.
Khan S; Shukla S; Sinha S; Lakra AD; Bora HK; Meeran SM
Int J Biochem Cell Biol; 2015 Jan; 58():1-16. PubMed ID: 25448414
[TBL] [Abstract][Full Text] [Related]
15. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
Chuang CH; Liu CH; Lu TJ; Hu ML
Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
[TBL] [Abstract][Full Text] [Related]
16. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
Chia JS; Du JL; Hsu WB; Sun A; Chiang CP; Wang WB
BMC Cancer; 2010 Apr; 10():175. PubMed ID: 20429953
[TBL] [Abstract][Full Text] [Related]
18. Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
Pratheeshkumar P; Son YO; Budhraja A; Wang X; Ding S; Wang L; Hitron A; Lee JC; Kim D; Divya SP; Chen G; Zhang Z; Luo J; Shi X
PLoS One; 2012; 7(12):e52279. PubMed ID: 23300633
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression.
Gupta P; Srivastava SK
Oncotarget; 2014 Apr; 5(7):1812-28. PubMed ID: 24729020
[TBL] [Abstract][Full Text] [Related]
20. Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis.
Thapa D; Lee JS; Heo SW; Lee YR; Kang KW; Kwak MK; Choi HG; Kim JA
Eur J Pharmacol; 2011 Jan; 650(1):64-71. PubMed ID: 20950604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
